Status:
COMPLETED
Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients
Lead Sponsor:
University of Pittsburgh
Conditions:
Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Infections caused by multidrug resistant bacteria have become more prevalent at many tertiary care and academic centers. These infections are associated with increased morbidity and mortality. The ini...
Detailed Description
Methods: Day 1 is when patients are admitted to the Transplant intensive care unit (ICU) following liver, intestinal or multivisceral transplantation. Stool samples (in the case of patients with rect...
Eligibility Criteria
Inclusion
- Patients in ICU who are identified as having undergone liver, intestinal or multivisceral transplantation. This includes cadaveric and living related liver transplants.
- Patients must be above 18 years of age.
- Patients undergoing re-transplantation may also be included.
- Written informed consent from patient or a proxy.
Exclusion
- Known colonization or infection with multidrug resistant (MDR) P. aeruginosa, MRSA or ESBL-Klebsiella prior to admission to the ICU.
- Pregnancy or nursing women
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00235664
Start Date
October 1 2005
End Date
December 1 2007
Last Update
December 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213